Amphotericin B and other polyenes—Discovery, clinical use, mode of action and drug resistance

H Carolus, S Pierson, K Lagrou, P Van Dijck - Journal of Fungi, 2020 - mdpi.com
Although polyenes were the first broad spectrum antifungal drugs on the market, after 70
years they are still the gold standard to treat a variety of fungal infections. Polyenes such as …

Cryptococcus gattii infections

SCA Chen, W Meyer, TC Sorrell - Clinical microbiology reviews, 2014 - Am Soc Microbiol
Understanding of the taxonomy and phylogeny of Cryptococcus gattii has been advanced by
modern molecular techniques. C. gattii probably diverged from Cryptococcus neoformans …

An official American Thoracic Society statement: treatment of fungal infections in adult pulmonary and critical care patients

AH Limper, KS Knox, GA Sarosi, NM Ampel… - American journal of …, 2011 - atsjournals.org
With increasing numbers of immune-compromised patients with malignancy, hematologic
disease, and HIV, as well as those receiving immunosupressive drug regimens for the …

Epidemiology of invasive mycoses in North America

MA Pfaller, DJ Diekema - Critical reviews in microbiology, 2010 - Taylor & Francis
The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …

[HTML][HTML] Lipid systems for the delivery of amphotericin B in antifungal therapy

C Faustino, L Pinheiro - Pharmaceutics, 2020 - mdpi.com
Amphotericin B (AmB), a broad-spectrum polyene antibiotic in the clinic for more than fifty
years, remains the gold standard in the treatment of life-threatening invasive fungal …

New pathogens, new tricks: emerging, drug‐resistant fungal pathogens and future prospects for antifungal therapeutics

J Geddes‐McAlister, RS Shapiro - … of the New York Academy of …, 2019 - Wiley Online Library
Fungal pathogens are a growing threat to public health. As human immunodeficiency
becomes increasingly common, fungal infections are becoming more prevalent. The use of …

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff …

A Espinel-Ingroff, AI Aller, E Canton… - Antimicrobial agents …, 2012 - Am Soc Microbiol
Epidemiological cutoff values (ECVs) for the Cryptococcus neoformans-Cryptococcus gattii
species complex versus fluconazole, itraconazole, posaconazole, and voriconazole are not …

Molecular mechanisms of 5-fluorocytosine resistance in yeasts and filamentous fungi

FZ Delma, AMS Al-Hatmi, RJM Brüggemann… - Journal of Fungi, 2021 - mdpi.com
Effective management and treatment of fungal diseases is hampered by poor diagnosis,
limited options for antifungal therapy, and the emergence of antifungal drug resistance. An …

Comparison of the Vitek 2 antifungal susceptibility system with the clinical and laboratory standards institute (CLSI) and European Committee on Antimicrobial …

M Cuenca-Estrella, A Gomez-Lopez… - Journal of clinical …, 2010 - Am Soc Microbiol
The commercial technique Vitek 2 system for antifungal susceptibility testing of yeast
species was evaluated. A collection of 154 clinical yeast isolates, including amphotericin B …

A new lineage of Cryptococcus gattii (VGV) discovered in the Central Zambezian Miombo Woodlands

RA Farrer, M Chang, MJ Davis, L van Dorp, DH Yang… - MBio, 2019 - Am Soc Microbiol
We discovered a new lineage of the globally important fungal pathogen Cryptococcus gattii
on the basis of analysis of six isolates collected from three locations spanning the Central …